SCIENTIFIC PROGRAM ORAL PRESENTATIONS. Friday October, 26 th OPENING SESSION
|
|
|
- Debra Wilson
- 5 years ago
- Views:
Transcription
1 SCIENTIFIC PROGRAM Friday October, 26 th OPENING SESSION 16:40-17:00 Opening lectures on Infectious Diseases 17:00-19:00 Opening lectures on Infectious Diseases Dr. Gerardo Guillén (Director of Biomedical Research at CIGB, Cuba) 20:00-21:00 WELCOME COCKTAIL 1
2 Saturday October, 27 th Dengue Symposium Dr. Diana Coronel and Dr. Beatriz Sierra 8:30-09:00 Dr. Beatriz Sierra, Cuba Different clinical outcome in Dengue: natural selection? 09:05-09:35 Dr. Vivian Huerta, Cuba Dengue virus interactome in human plasma reveals a novel target to develop antiviral drugs against the viral complex 09:40-10:10 Dr. Diana Coronel, Mexico Dengvaxia vaccine: update 10:15-10:45 Dr. Lazaro Gil, Cuba An update on Dengue Vaccine Candidates: the Cuban experience 11:00-11:20 2
3 Saturday October, 27 th Dr. Oliver Pérez 11:20-11:45 Dr. Oliver Pérez, Cuba Challenging the adjuvant s Gaston definition 11:50-12:15 Dr. Annele Roque, Cuba Plants and marine algae as alternative sources for antiviral drugs 12:20-12:45 Dr. Oscar Ledea, Cuba Preclinical and Clinical evidences of the antibacterial and parasitical actions of OLEOZON 12:50-13:10 To be announced 13:15-14:30 14:30-16:00 POSTER SESSION 3
4 Sunday October, 28 th Viral Hepatitis Symposium Prof. Beat Meier and Prof. Eduardo Pentón 8:30-09:00 Dr. Anja Bo ckmann, France Solid-state NMR investigation of capsids and envelopes from the Hepatitis B particle 09:05-09:30 Dr. Guillermo Fernández, Cuba Five year follow-up of chronic hepatitis B patients immunized by nasal route with the therapeutic vaccine HeberNasvac 09:35-10:00 Dr. Jorge Aguiar, Cuba Robustness of a low cost HBV-DNA quantitative system, a potential partner in the introduction and follow-up of a novel therapeutic vaccine versus chronic hepatitis B 10:05-10:30 Dr. Julio C. Aguilar, Cuba HEBERNASVAC, crossroad of biotechnology, vaccinology and liver immunology 10:35-10:55 4
5 Sunday October, 28 th Viral Hepatitis Symposium Prof. Beat Meier and Prof. Eduardo Pentón 11:00-11:25 Prof. Eduardo Pentón, Cuba Clinical trials of Chronic Hepatitis B therapeutic vaccines and novel therapeutic agents under clinical development 11:30-11:55 Prof. Beat H. Meier, Switzerland Solid-state NMR of two nonstructural proteins of Hepatitis C 12:00-12:25 MSc. Santa M. Olivera, Cuba Hepatitis C preventive vaccine based on a chimeric protein strategy 12:30-14:00 14:30-16:00 POSTER SESSION 5
6 Monday October, 29 th HIV Symposium Dr. Mosef Benkirane and Dr. Celia Fernández 8:30-09:00 Dr. Marie-Lise Gougeon, France How Innate Immune Cells Contribute to the establishment of HIV reservoirs? 09:05-09:25 Dr. Enrique Iglesias, Cuba Safety assessment of the vaccine candidate TERAVAC-HIV- 1 in a phase I Therapeutic Clinical Trial 09:30-09:50 Dr. Ingrid Rodríguez, Cuba HIV-specific antibodies and cellular immune response after Teravac vaccination in seropositive patients 09:55-10:15 Dr. Celia Fernández-Ortega, Cuba A peptide that penetrates human cell lines inhibits the HIV replication through the modulation of vimentin 10:20-10:35 Dr. Monsef Benkirane, France Impact of 3D genome organization on HIV integration site selection 10:50-11:10 Dr. Luca Shytaj, Germany HIV-1 replication alters redox and iron metabolism to deplete the latency marker PML in CD4+ T-cells 6
7 11:15-11:45 Dr. Celia Fernández Ortega, Cuba Closing remarks, Selection of outstanding posters. 7
Five-year Follow-up of Chronic Hepatitis B Patients Immunized by Nasal Route with the Therapeutic Vaccine HeberNasvac
RESEARCH ARTICLE 10.5005/jp-journals-10018-1279 Five-year Follow-up of Chronic Hepatitis B Patients Immunized by Nasal Route with the Therapeutic Vaccine HeberNasvac 1 Guillermo Fernández, 1 Ana L Sanchez,
Hepatitis B. HBV Cure: Insights for the Biotechnology and the Research Analyst Community November 11, Lalo Flores, PhD Global Head HBV R&D
Hepatitis B HBV Cure: Insights for the Biotechnology and the Research Analyst Community November 11, 2016 Lalo Flores, PhD Global Head HBV R&D Infectious Diseases Diseases Infectious 11 Janssen s Vision
Microbiological Societies (IUMS) Congress This conference took place in Montreal, CANADA during
(Abroad Domestic)Official trip report form(student) 2014/08/19 (Year/Month/Day) Name Laboratory Year (Grade) Destination Nipawit Karnbunchob Division of Bioinformatics DC2 Montreal, CANADA Period of trip
We have one of the World s Most Advanced Functional HIV Cures under development
Source : labiotech.eu, 04/07/2016 We have one of the World s Most Advanced Functional HIV Cures under development Abivax has recently announced that it s likely that its most advanced program in hepatitis
EACS HIV Summer School PRELIMINARY PROGRAMME
EACS HIV Summer School Thursday, August 30, 2018 Monday, September 3, 2018 Montpellier, France This 5-day residential course is designed for clinicians experienced in HIV management who want an update
1. Virus 2. Capsid 3. Envelope
VIRUSES BIOLOGY II VOCABULARY- VIRUSES (22 Words) 1. Virus 2. Capsid 3. Envelope 4. Provirus 5. Retrovirus 6. Reverse transcriptase 7. Bacteriophage 8. Lytic Cycle 9. Virulent 10. Lysis 11. Lysogenic Cycle
Atul Humar, MD, MSc Director, Transplant Program, University Health Network, University of Toronto
TIME PROGRAM TITLE 7:30 8:15 Registration and Continental Breakfast 8:15 8:30 Welcoming Remarks TOPIC: VIRUSES Session Chair: Shahid Husain CMV: What is New, What s Hot Atul Humar, MD, MSc Director, Transplant
LYON. FRANCE NOVEMBER / 2013 TRANSLATIONAL RESEARCH IN CHRONIC VIRAL HEPATITIS - BRIDGING BASIC SCIENCE AND CLINICAL RESEARCH
LYON. FRANCE NOVEMBER 29-30 / 2013 TRANSLATIONAL RESEARCH IN CHRONIC VIRAL HEPATITIS - BRIDGING BASIC SCIENCE https://events.easl.eu/eventportal/ Information/MLYON2013/HOME.aspx Abstract submission deadline:
Viruses 101., and concluded that living organisms do not crystallize. In other words,.
Viruses 101 In 1897, Dutch scientist called tiny particles in the liquid extracted from a plant disease, which is the Latin word for. In 1935, American biochemist isolated crystals of, and concluded that
General Virology I. Dr Esam Ibraheem Azhar (BSc, MSc, Ph.D Molecular Medical Virology) Asst. Prof. Medical Laboratory Technology Department
General Virology I Dr Esam Ibraheem Azhar (BSc, MSc, Ph.D Molecular Medical Virology) Asst. Prof. Medical Laboratory Technology Department ١ General Virology I Lecture Outline Introduction istory Definition
Hepatitis B Virus infection: virology
Hepatitis B Virus infection: virology 167 Falk Symposium: Liver under constant attack from fat to viruses III Falk Gastro-Konferenz 17.-21. September 2008 Congress Centrum Mainz Maura Dandri Department
Overview: Chapter 19 Viruses: A Borrowed Life
Overview: Chapter 19 Viruses: A Borrowed Life Viruses called bacteriophages can infect and set in motion a genetic takeover of bacteria, such as Escherichia coli Viruses lead a kind of borrowed life between
Chapter 13 Viruses, Viroids, and Prions. Biology 1009 Microbiology Johnson-Summer 2003
Chapter 13 Viruses, Viroids, and Prions Biology 1009 Microbiology Johnson-Summer 2003 Viruses Virology-study of viruses Characteristics: acellular obligate intracellular parasites no ribosomes or means
Protein Structure and Computational Biology, Good morning and welcome!
Protein Structure and Computational Biology, 27617 Good morning and welcome! Program 9.00-9.30 Introduction to the course 9.30-9.40 Break 9.40-10.00 Introduction to influenza a recurring case story 10.00-10.10
VACCINE ENGINEERING Dr.T.V.Rao MD
VACCINE ENGINEERING Dr.T.V.Rao MD DR.T.V.RAO MD 1 HISTORICAL PICTURE OF VACCINATION DR.T.V.RAO MD 2 WHAT IS A VACCINE A vaccine is any preparation intended to produce immunity to a disease by stimulating
19/06/2013. Viruses are not organisms (do not belong to any kingdom). Viruses are not made of cells, have no cytoplasm, and no membranes.
VIRUSES Many diseases of plants and animals are caused by bacteria or viruses that invade the body. Bacteria and viruses are NOT similar kinds of micro-organisms. Bacteria are classified as living organisms,
Index. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Adaptive immune response biologic response modifiers and, 735 737 S-Adenosylmethionine (SAMe) for hepatitis, 825 826 Albinterferon for hepatitis,
Infectious Diseases. Colin R. Howard ( 郝高林 ) Royal Veterinary College University of London ( 伦敦大学皇家兽医学院 )
Infectious Diseases Colin R. Howard ( 郝高林 ) Royal Veterinary College University of London ( 伦敦大学皇家兽医学院 ) The Challenge of Infectious Disease Infectious disease represents the greatest challenge to mankind
Biodiversity: prokaryotes & viruses
Biodiversity: prokaryotes & viruses All three domains contain microscopic organisms. Focus now: Prokaryotes Prokaryotes in general Asexual, single-celled, no nucleus or organelles, circular DNA Can live
Viruses. CLS 212: Medical Microbiology Miss Zeina Alkudmani
Viruses CLS 212: Medical Microbiology Miss Zeina Alkudmani History Through the 1800s, many scientists discovered that something smaller than bacteria could cause disease and they called it virion (Latin
GLOBAL INVESTMENT IN HIV CURE RESEARCH AND DEVELOPMENT IN 2017 AFTER YEARS OF RAPID GROWTH FUNDING INCREASES SLOW
GLOBAL INVESTMENT IN HIV CURE RESEARCH AND DEVELOPMENT IN 2017 AFTER YEARS OF RAPID GROWTH FUNDING INCREASES SLOW TOWARDS AN CURE PEOPLE FOCUSED SCIENCE DRIVEN JULY 2018 A GLOBAL STRATEGIC APPROACH TOWARDS
Isolated Hepatitis B Core Antibody
NORTHWEST AIDS EDUCATION AND TRAINING CENTER Isolated Hepatitis B Core Antibody Nina Kim, MD MSc Associate Professor of Medicine November 13, 2014 Isolated Core Antibody Virology & terminology Definition
PROGRAM RNA VIRUS PERSISTENCE MEETING: MECHANISMS AND CONSEQUENCES. AUGUST 23-25, 2018 Institute of Virology, Medical Center - University of Freiburg
PROGRAM RNA VIRUS PERSISTENCE MEETING: MECHANISMS AND CONSEQUENCES AUGUST 23-25, 2018 Institute of Virology, Medical Center - University of Freiburg WELCOME Mechanisms and consequences of RNA virus persistent
SECTION 25-1 REVIEW STRUCTURE. 1. The diameter of viruses ranges from about a. 1 to 2 nm. b. 20 to 250 nm. c. 1 to 2 µm. d. 20 to 250 µm.
SECTION 25-1 REVIEW STRUCTURE VOCABULARY REVIEW Define the following terms. 1. virus 2. capsid 3. retrovirus 4. viroid 5. prion MULTIPLE CHOICE Write the correct letter in the blank. 1. The diameter of
Antiviral Drugs Lecture 5
Antiviral Drugs Lecture 5 Antimicrobial Chemotherapy (MLAB 366) 1 Dr. Mohamed A. El-Sakhawy 2 Introduction Viruses are microscopic organisms that can infect all living cells. They are parasitic and multiply
VIRUSES. 1. Describe the structure of a virus by completing the following chart.
AP BIOLOGY MOLECULAR GENETICS ACTIVITY #3 NAME DATE HOUR VIRUSES 1. Describe the structure of a virus by completing the following chart. Viral Part Description of Part 2. Some viruses have an envelope
Structure & Function of Viruses
Structure & Function of Viruses Discovery of Viruses Louis Pasteur- looks for a causative agent for rabies, says too small, can not find it 1892 Dimitry Ivanosky- studies tobacco disease, can not find
LEC 2, Medical biology, Theory, prepared by Dr. AYAT ALI
General Characteristics, Structure and Taxonomy of Viruses Viruses A virus is non-cellular organisms made up of genetic material and protein that can invade living cells. They are considered both a living
Available online at Procedia in Vaccinology 2 (2010)
Available online at www.sciencedirect.com Procedia in Vaccinology 2 (2010) 128 133 Ninth Global Vaccine Research Forum and Parallel Satellite Symposia, Bamako, Mali, 6-9 December 2009 Virus-Like Particles
History electron microscopes
Viruses History Through the 1800s, many scientists discovered that something smaller than bacteria could cause disease and they called it virion (Latin word- poison) In the 1930s, after the invention of
HPV AND CERVICAL CANCER
HPV AND CERVICAL CANCER DR SANDJONG TIECHOU ISAAC DELON Postgraduate Training in Reproductive Health Research Faculty of Medicine, University of Yaoundé 2007 INTRODUCTION CERVICAL CANCER IS THE SECOND
IAS 2013 Towards an HIV Cure Symposium
In chronically HIV-1-infected patients long-term antiretroviral therapy initiated above 500 CD4/mm 3 achieves better HIV-1 reservoirs' depletion and T-cell count restoration IAS 2013 Towards an HIV Cure
Emerging Viruses. Part IIb Follow Up from Part I Vaccines and Inhibitors
Emerging Viruses Part IIb Follow Up from Part I Vaccines and Inhibitors Cellular Responses to Viral Invasion: Restriction Factors Cells fight viral infection using a series of restriction factors Restriction
In Case of Technical Difficulties
Interview with Stanley A. Plotkin, MD: Greatest Vaccinology Discoveries of the Last Decade and Future Predictions Wednesday, February 15, 2017 12:00 PM ET In Case of Technical Difficulties If you hear
Getting the Most Out of Baculovirus. Linda Lua
Getting the Most Out of Baculovirus Linda Lua Enabling World Class Research Recombinant Protein Production Discovery, Translational, Preclinical Drug discovery, vaccinology, diagnostics, functional materials,
A VACCINE FOR HIV BIOE 301 LECTURE 10 MITALI BANERJEE HAART
BIOE 301 LECTURE 10 MITALI BANERJEE A VACCINE FOR HIV HIV HAART Visit wikipedia.org and learn the mechanism of action of the five classes of antiretroviral drugs. (1) Reverse transcriptase inhibitors (RTIs)
MONTGOMERY COUNTY COMMUNITY COLLEGE CHAPTER 13: VIRUSES. 1. Obligate intracellular parasites that multiply in living host cells
MONTGOMERY COUNTY COMMUNITY COLLEGE CHAPTER 13: VIRUSES I. CHARACTERISTICS OF VIRUSES A. General Characteristics 1. Obligate intracellular parasites that multiply in living host cells 2. Contain a single
Trends in Immunological Memory and Vaccine Development
The 2 nd Symposium of International Immunological Memory and Vaccine Forum (IIMVF) Trends in Immunological Memory and Vaccine Development August 25-26, 2014 La Jolla Institute of Allergy & Immunology La
18.2 Viruses and Prions
KEY CONCEPT Infections can be caused in several ways. Viruses, bacteria, viroids, and prions can all cause infection. Any disease-causing agent is called a pathogen. 1 nanometer (nm) = one billionth of
FOCIS goes South: ADVANCES IN TRANSLATIONAL AND CLINICAL IMMUNOLOGY
FOCIS Center of Excellence Millennium Institute on Immunology and Immunotherapy & The Federation of Clinical Immunology Societies, FOCIS WORKSHOP FOCIS goes South: ADVANCES IN TRANSLATIONAL AND CLINICAL
Part I. Content: History of Viruses. General properties of viruses. Viral structure. Viral classifications. Virus-like agents.
Viruses Part I Content: History of Viruses. General properties of viruses. Viral structure. Viral classifications. Virus-like agents. History Through the 1800s, many scientists discovered that something
LESSON 4.6 WORKBOOK. Designing an antiviral drug The challenge of HIV
LESSON 4.6 WORKBOOK Designing an antiviral drug The challenge of HIV In the last two lessons we discussed the how the viral life cycle causes host cell damage. But is there anything we can do to prevent
Additional Presentation Demonstrates Potential Mechanisms for Unprecedented HIV Reservoir Depletion by SB-728-T
September 8, 2014 Sangamo BioSciences Announces Presentation At ICAAC of New Clinical Data Demonstrating Sustained Functional Control of Viremia in Multiple HIV- Infected Subjects Treated with SB-728-T
Principles of Molecular Virology STAGE / YEAR: 3 CREDITS: 10. PROGRAMME COMMITTEE: Biomedical Sciences. VERSION: 4th March 2015
MODULE: MODULE NUMBER: JACS CODE: Principles of Molecular Virology BIO00041H C540 STAGE / YEAR: 3 CREDITS: 10 ORGANISER: Nathalie Signoret PROGRAMME COMMITTEE: Biomedical Sciences VERSION: 4th March 2015
BIOLOGICAL DIVERSITY: VIRUSES
BIOLOGICAL DIVERSITY: VIRUSES Viruses: a Group of Intracellular Parasites In the 19th century, many rabies cases plagued Europe. In London, for example, 29 deaths by "hydrophobia" were enumerated in the
Biotechnology-Based Vaccines. Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel:
Biotechnology-Based Vaccines Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa Objectives of this lecture By the end of this lecture you will be able to: 1.
virology MCQs 2- A virus commonly transmitted by use of contaminated surgical tools & needles produces a disease called serum hepatitis.
virology MCQs 1- A virus which causes AIDS is: a- Small pox virus. b- Coxsackie B virus. c- Mumps virus. d- Rubella virus. e- HIV-III virus. 2- A virus commonly transmitted by use of contaminated surgical
Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics
Hepadnaviruses Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Hepatitis viruses A group of unrelated pathogens termed hepatitis viruses cause the vast majority
The Biology of Viruses MMI / Biochem 575 SPRING 2015
The Biology of Viruses MMI / Biochem 575 SPRING 2015 INSTRUCTORS: Professor Paul Friesen Professor Andrew Mehle INTRODUCTION: The goal of Biology of Viruses (MMI/Biochem 575) is to introduce upperlevel
Pathogens and the immune system
Pathogens and the immune system Veronica Leautaud, Ph.D. vl2@ rice.edu Keck Hall 224 / 232-lab Lecture 8 BIOE 301-Bioengineering and World Health Review of lecture 7 Science Science is the human activity
Science World Journal of Cancer Science and Therapy
Open Access Journal Volume: 1.1 Science World Journal of Cancer Science and Therapy Establishment of Investment after Manufacturing Natural Remedy for Blood Circulation Virus Killing Immune Oncology Cured
New prospects for vaccination: from polio to dengue and flu
New prospects for vaccination: from polio to dengue and flu From ancient Chinese variolation to Jenner and cowpox Paul Young Australian Infectious Diseases Research Centre School of Chemistry and Molecular
Rama Nada. - Malik
- 2 - Rama Nada - - Malik 1 P a g e We talked about HAV in the previous lecture, now we ll continue the remaining types.. Hepatitis E It s similar to virus that infect swine, so its most likely infect
DEPARTMENT OF VIROLOGY
DEPARTMENT OF VIROLOGY NELSON R MANDELA SCHOOL OF MEDICINE, UNIVERSITY OF KWAZULU-NATAL, and INKOSI ALBERT LUTHULI CENTRAL HOSPITAL, KZN BRANCH, NATIONAL HEALTH LABORATORY SERVICE Biomedscience III Virology
What's the future for animal vaccines?
What's the future for animal vaccines? Diego G. Diel, DVM, MS, PhD Assistant Professor Department of Veterinary and Biomedical Sciences South Dakota State University E-mail: diego.diel@sdstate.edu Outline
Syllabus: Principles of Virology
Syllabus: Principles of Virology 1. Course Infromation: Title: Principles of Virology Number: F494 Credits: 3 Prerequisits: Biol 261 Location: To be determined 2. Instructor contact information: Karsten
BIOLOGICAL DIVERSITY: VIRUSES
BIOLOGICAL DIVERSITY: VIRUSES Viruses: a Group of Intracellular Parasites In the 19th century, many rabies cases plagued Europe. In London, for example, 29 deaths by "hydrophobia" were enumerated in the
"Development and Clinical Progress. of DNA Vaccines" Program
Paul-Ehrlich-Institut International Conference "Development and Clinical Progress of DNA Vaccines" Paul-Ehrlich-Institut, Langen, Germany October 6-8, 1999 Program CBER/FDA INTERNATIONAL ASSOCIATION FOR
PROPOSAL FOR THE DEVELOPMENT OF AN INTERNATIONAL REFERENCE PREPARATION FOR HEPATITIS D VIRUS RNA
PROPOSAL FOR THE DEVELOPMENT OF AN INTERNATIONAL REFERENCE PREPARATION FOR HEPATITIS D VIRUS RNA SoGAT Clinical Diagnostics II 30 September / 1 October 2009, Istanbul Michael Chudy Julia Kreß C. Micha
Block 1. Immunology and Principles of Vaccination
The Institute for International Cooperation in Animal Biologics (IICAB) is offering a eleven-day Veterinary Biologics Training Program beginning May 9, 2007 in Ames, Iowa. The course is sponsored by the
AANP. American Association of Neuropathologists. 93 rd Annual Meeting. June 8-11 Orange County, California. Meeting at a Glance
AANP American Association of Neuropathologists 2017 93 rd Annual Meeting June 8-11 Orange County, California Meeting at a Glance 2017 SPECIAL COURSE Genetics, Genomics, and Epigenomics in Clinical Neuropathology
Hepatitis B Antiviral Drug Development Multi-Marker Screening Assay
Hepatitis B Antiviral Drug Development Multi-Marker Screening Assay Background ImQuest BioSciences has developed and qualified a single-plate method to expedite the screening of antiviral agents against
Clinical overview of GSK s AS04 adjuvanted vaccine: data up to 6.4 years
Clinical overview of GSK s AS04 adjuvanted vaccine: data up to 6.4 years Gudrun Maechler Director, Clinical & Medical Affairs Europe & Cervarix GSK Biologicals Presentation Outline HPV immunology Immunogenicity
REPORT US - CUBA SCIENTIFIC EXCHANGE PROGRAM. March 29 April 3, Supported by a grant from
REPORT US - CUBA SCIENTIFIC EXCHANGE PROGRAM March 29 April 3, 2016 Supported by a grant from Purpose The purpose of the PSDCF U.S-Cuba Scientific Exchange program is to connect leading United States diabetes
Trends in vaccinology
Trends in vaccinology Mathieu Peeters, MD Joint Conference of European Human Pharmacological Societies and Joint Conference of European Human Pharmacological Societies and 20th Anniversary of AGAH March
CIDRAP Leadership Forum Infectious Disease BRIEFING
Center for Infectious Disease Research and Policy University of Minnesota CIDRAP Leadership Forum Infectious Disease BRIEFING December 13 th, 2017 CLF BRIEFING HOT TOPICS 1. Influenza (surveillance, vaccine,
Immunodeficiency. (2 of 2)
Immunodeficiency (2 of 2) Acquired (secondary) immunodeficiencies More common Many causes such as therapy, cancer, sarcoidosis, malnutrition, infection & renal disease The most common of which is therapy-related
Persistent Infections
Persistent Infections Lecture 17 Biology 3310/4310 Virology Spring 2017 Paralyze resistance with persistence WOODY HAYES Acute vs persistent infections Acute infection - rapid and self-limiting Persistent
Forward Looking Statements
Slide title Forward Looking Statements This presentation may contain forward looking statements with respect to the financial condition, results and business achievements/performance of Biotron Limited
Discovery of. 1892: Russian biologist Dmitri Ivanovsky publishes. 1931: first images of viruses obtained using
Discovery of (1884: invention of the Chamberland filter with pores smaller than bacteria) 1892: Russian biologist Dmitri Ivanovsky publishes a paper in which shows that extracts from diseased tobacco plants
Unit 4 Student Guided Notes
Structure of Viruses Discovery of the Virus Unit 4 Student Guided Notes Many human epidemics were well documented and observed in history, but. The following 3 discoveries shaped our knowledge of viruses
Lecture Guide Viruses (CH13)
Lecture Guide Viruses (CH13) This chapter is on the general characteristics of viruses and focuses on both bacterial and animal viruses and their life cycles. Let s start with a quick look at the history
Dr. Gary Mumaugh. Viruses
Dr. Gary Mumaugh Viruses Viruses in History In 1898, Friedrich Loeffler and Paul Frosch found evidence that the cause of foot-and-mouth disease in livestock was an infectious particle smaller than any
Nucleic acid: singled stranded, double stranded, RNA, or DNA, linear or circular. Capsid: protein coat that is most of the mass of the virus.
Viruses General Characteristics of Viruses 1. Depending on view may be regarded as exceptionally complex aggregates of nonliving chemicals or as exceptionally simple living microbes. 2. Contain a single
Structure of viruses
Antiviral Drugs o Viruses are obligate intracellular parasites. o lack both a cell wall and a cell membrane. o They do not carry out metabolic processes. o Viruses use much of the host s metabolic machinery.
Biomedical Engineering for Global Health. Lecture 10 HIV/AIDS vaccine development
Biomedical Engineering for Global Health Lecture 10 HIV/AIDS vaccine development Review of lecture 9 How do vaccines work? Types ofvaccines: Review of lecture 9 Are vaccines effective? -Edward Jenner s
Chapter 6- An Introduction to Viruses*
Chapter 6- An Introduction to Viruses* *Lecture notes are to be used as a study guide only and do not represent the comprehensive information you will need to know for the exams. 6.1 Overview of Viruses
International Hepatitis Symposium Heidelberg
16 th May 18 th May 2018 International Hepatitis Symposium Heidelberg Ralf Bartenschlager s 60 th Birthday Symposium (16 th ) AND International Symposium of the TRR179 (17 th to 18 th ) Confirmed Speakers:
Viral structure م.م رنا مشعل
Viral structure م.م رنا مشعل Viruses must reproduce (replicate) within cells, because they cannot generate energy or synthesize proteins. Because they can reproduce only within cells, viruses are obligate
Bacteria & Viruses. Biology Science Department
Bacteria & Viruses What do you already know? What are the differences between viruses and bacteria? Are all bacteria harmful? When you get a cold, should you take an antibiotic to help you get better?
Some living things are made of ONE cell, and are called. Other organisms are composed of many cells, and are called. (SEE PAGE 6)
Section: 1.1 Question of the Day: Name: Review of Old Information: N/A New Information: We tend to only think of animals as living. However, there is a great diversity of organisms that we consider living
Unit 13.2: Viruses. Vocabulary capsid latency vaccine virion
Unit 13.2: Viruses Lesson Objectives Describe the structure of viruses. Outline the discovery and origins of viruses. Explain how viruses replicate. Explain how viruses cause human disease. Describe how
Chapter 19: The Genetics of Viruses and Bacteria
Chapter 19: The Genetics of Viruses and Bacteria What is Microbiology? Microbiology is the science that studies microorganisms = living things that are too small to be seen with the naked eye Microorganisms
DOES HEPATITIS D IN HBV/HIV CO-INFECTED PATIENTS AFFECT LIVER FUNCTION?
DOES HEPATITIS D IN HBV/HIV CO-INFECTED PATIENTS AFFECT LIVER FUNCTION? *Joanna Kozłowska, **Joanna Kubicka, *Joanna Jabłońska, *Tomasz Mikuła, **Ewa Siwak, ***Tomasz Dyda, *Alicja Wiercińska-Drapało *Hepatology
Newsletter. August 7, Visit
Share: Tweet Newsletter August 7, 2013 Jump to a Topic: Upcoming Events Funding Opportunities Conferences and Meetings Announcements Check out our new website! We are excited to announce the launching
Ch. 19 Viruses & Bacteria: What Is a Virus?
Ch. 19 Viruses & Bacteria: What Is a Virus? A virus is an invective agent consisting of a nucleic acid in a protein coat, able to multiply only within the living cells of a host. A bacteriophage ( bacteria
Chapter13 Characterizing and Classifying Viruses, Viroids, and Prions
Chapter13 Characterizing and Classifying Viruses, Viroids, and Prions 11/20/2017 MDufilho 1 Characteristics of Viruses Viruses Minuscule, acellular, infectious agent having either DNA or RNA Cause infections
Viruses. Rotavirus (causes stomach flu) HIV virus
Viruses Rotavirus (causes stomach flu) HIV virus What is a virus? A virus is a microscopic, infectious agent that may infect any type of living cell. Viruses must infect living cells in order to make more
Viruses and cancer: Should we be more afraid?
Viruses and cancer: Should we be more afraid? Viruses and cancer: Should we be more afraid? During the past 30 years it has become exceedingly clear that several viruses play significant roles in the development
Lipid Based Drug Delivery Systems Focus Group
Lipid Based Drug Delivery Systems Focus Group Monday, November 11, 2013 12:15 pm- 1:15 pm Room 006 CD Henry B. Gonzalez Convention Center Welcome to the Great State of Texas! AAPS Lipid Based Drug Delivery
AG Kaderali Bioinformatics / Mathematical Modeling of Infection
AG Kaderali Bioinformatics / Mathematical Modeling of Infection Prof. Dr. Lars Kaderali Hiddensee, October 27, 2015 Institut für Bioinformatik Research Overview Experimental Data High-Throughput Screening
Lahore University of Management Sciences. BIO314 Virology and Microbiology (Spring 2015)
BIO314 Virology and Microbiology (Spring 2015) Instructor Room. Office Hours Email Telephone Secretary/TA TA Office Hours Course URL (if any) Shaper Mirza and Sadia Hamera Shaper.Mirza@uth.tmc.edu Course
Immunopathogenesis of Dengue Hemorrhagic Fever
Immunopathogenesis of Dengue Hemorrhagic Fever Carlos A. Sariol, MD, MS. Associated Investigator School of Medicine, MSC-UPR September 17th, 2009 Foro Educativo para Maestros de Ciencias en la UPRH September
Effect of 24 Week Intensification with a CCR5-Antagonist on the Decay of the HIV-1 Latent Reservoir
Effect of 24 Week Intensification with a CCR5-Antagonist on the Decay of the HIV-1 Latent Reservoir Laura Díaz 1, Carolina Gutiérrez 2, Carmen Page 2, Raquel Lorente 1, Beatriz Hernández-Novoa 2, Alejandro
Section Lectures: Immunology/Virology Time: 9:00 am 10:00 am LRC 105 A & B
Section Director: Cliff Bellone, Ph.D. Office: Doisy Hall - R 405 Phone: 577-8449 E-Mail: bellonec@slu.edu Lecturers: James Swierkosz, Ph.D. Office: Medical School Rm. 412 Phone: 577-8430 E-Mail: swierkoszje@slu.edu
Conference Program. (Published: August 9, 2017) Hosted by:
Conference Program (Published: August 9, 2017) Hosted by: Friday, September 15 09:00-13:00 Registration Delegates and Speakers Disease- & Region-specific Discussions 12:00 13:00 Lunch 13:00-13:45 Conference
All living creatures share two basic purposes 1. survival 2. reproduction
Infectious Diseases All living creatures share two basic purposes 1. survival 2. reproduction *Organisms must take nutrients essential for growth and proliferation from the environment. *In many conditions
Human Immunodeficiency Virus
Human Immunodeficiency Virus Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Viruses and hosts Lentivirus from Latin lentis (slow), for slow progression of disease
PROCEDURE Follow the instructions as you proceed through the Click and Learn, and answer the questions in the spaces provided.
ABOUT THIS WORKSHEET This worksheet complements the Click and Learn developed in conjunction with the 2016 documentary, Spillover: Zika, Ebola & Beyond (http://www.hhmi.org/biointeractive/virusexplorer).